Frequency and timing of symptoms in infants screened for sepsis: Effectiveness of a sepsis-screening pathway

被引:3
作者
Madan, A
Adams, MM
Philip, AGS
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] El Camino Hosp, Mountain View, CA USA
关键词
D O I
10.1177/000992280304200102
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To determine the frequency and timing of symptoms and to evaluate the effectiveness of a sepsis-screcning pathway in term and near-term infants, data were collected prospectively for a period of I year from December 1, 2000, to November 30, 2001. Results confirmed that a sepsis-screening pathway using a combination of at least 2 serial complete blood cell count and C-reactive protein measurements in both symptomatic and asymptomatic infants is a safe, simple strategy that prevents unnecessary treatment of infants with risk factors with antibiotics. However, most infants with presumed or suspected early-onset sepsis are symptomatic. Routine treatment of asymptomatic infants with risk factors or prior treatment with intrapartum antibiotics is unnecessary. A combined approach of screening in the presence of risk factors and/or symptoms of sepsis and adequate follow-up for infants discharged at less than 72 hours of age may help reduce unnecessary treatment of infants with antibiotics.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 43 条
  • [1] Antimicrobial prevention of early-onset group B streptococcal sepsis: Estimates of risk reduction based on a critical literature review
    Benitz, WE
    Gould, JB
    Druzin, ML
    [J]. PEDIATRICS, 1999, 103 (06)
  • [2] Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77
  • [3] Serial serum C-reactive protein levels in the diagnosis of neonatal infection
    Benitz, WE
    Han, MY
    Madan, A
    Ramachandra, P
    [J]. PEDIATRICS, 1998, 102 (04) : E41
  • [4] Vancomycin-resistant Enterococcus - Detection, epidemiology, and control measures
    Boyce, JM
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (02) : 367 - &
  • [5] SELECTIVE INTRAPARTUM CHEMOPROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL EARLY-ONSET DISEASE .1. EPIDEMIOLOGIC RATIONALE
    BOYER, KM
    GADZALA, CA
    BURD, LI
    FISHER, DE
    PATON, JB
    GOTOFF, SP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) : 795 - 801
  • [6] The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants
    Bromberger, P
    Lawrence, JM
    Braun, D
    Saunders, B
    Contreras, R
    Petitti, DB
    [J]. PEDIATRICS, 2000, 106 (02) : 244 - 250
  • [7] Chiesa C, 2001, CLIN CHEM, V47, P1016
  • [8] C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection
    Ehl, S
    Gering, B
    Bartmann, P
    Hogel, J
    Pohlandt, F
    [J]. PEDIATRICS, 1997, 99 (02) : 216 - 221
  • [9] EARLY DISCONTINUATION OF ANTIBIOTIC-TREATMENT IN NEWBORNS ADMITTED TO RULE OUT SEPSIS - A DECISION RULE
    ESCOBAR, GJ
    ZUKIN, T
    USATIN, MS
    LEMESURIER, J
    HONEYCHURCH, D
    ARMSTRONG, MA
    FOLCK, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (10) : 860 - 866
  • [10] Rehospitalization in the first two weeks after discharge from the neonatal intensive care unit
    Escobar, GJ
    Joffe, S
    Gardner, MN
    Armstrong, MA
    Folck, BF
    Carpenter, DM
    [J]. PEDIATRICS, 1999, 104 (01) : e2